I'm looking for

All News

New DOD Ovarian Cancer Research Program Clinical Trial Award, Letters of Intent Due June 22

News Article
Jun 9, 2022

The Department of Defense (DoD) Ovarian Cancer Research Program (OCRP) is offering a new Clinical Trial Award with $1.5 million in available funds for FY 2022. Letters of intent for this award are due June 22, 2022, by 5:00 p.m. EDT, and applications are due August 5, 2022, by 11:59 p.m. EDT.

The OCRP Clinical Trial Award supports the rapid implementation of clinical trials with the potential to have a significant impact on the treatment or management of ovarian cancer. Clinical trials may be designed to evaluate promising new products, pharmacologic agents (drugs or biologics), devices, clinical guidance, and/or emerging approaches and technologies. Independent investigators at all academic levels are eligible to apply for this new award. More information and application instructions can be found online.

Please accept [renew_consent]%cookie_types[/renew_consent] cookies to watch this video.